Investar Holding (NASDAQ:ISTR) reported quarterly earnings of $0.62 per share which missed the analyst consensus estimate of $0.71 by 12.68 percent. This is a 10.71 percent increase over earnings of $0.56 per share from the same period last year.
Mizuho Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $27
Mizuho analyst Vamil Divan maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and lowers the price target from $28 to $27.